For the last five years, every Alzheimer’s conference has featured at least one talk on artificial intelligence and risk prediction. The promise has always been the same: combine blood tests, […]
For the last five years, every Alzheimer’s conference has featured at least one talk on artificial intelligence and risk prediction. The promise has always been the same: combine blood tests, […]
The hormones-and-cognition conversation is one of the oldest and most relitigated debates in women’s health. A big study in 2003 (the Women’s Health Initiative Memory Study) scared a generation of […]
Part 5 — Inflammation In The Brain Is The Common Thread Step back and look at the papers so far. Those four topics share one floor underneath all of them: […]
We need to settle a question that has been unresolved since Long Covid was first described. Does the brain fog of Long COVID resolve on its own? The best 36-month […]
Exercise is the intervention every doctor recommends and most people under-do. The 2026 data cleared up two things that have been fuzzy for years: which type of movement works best, […]
Four papers this year pushed the metabolism story from “important” to “probably the most actionable lever we have in preventing cognitive decline.” They came from different research traditions — pharmacology, […]
The 2023 headlines about two new Alzheimer’s drugs, lecanemab and donanemab, made it sound like the science was settled. Amyloid, a sticky protein that builds up in the brains of […]
From the Rezilir Health clinical team. May 2026. Why we wrote this Most weeks, someone sits down in our office with a news clipping in their hand. Sometimes it’s about […]
Why the Difference Matters—Especially for Your Brain When most people think about “healthcare,” they are often actually thinking about something quite different: sick care. Although these terms are frequently used […]